Breaking News, Financial News

Financial Report: WuXi Pharma Tech 3Q

Lab Services up 26%, driven by China-based labs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi Pharma Tech 3Q Revenues: $125.8 million (+21%) 3Q Earnings: $213 million (+3%) YTD Revenues: $374.3 million (+25%) YTD Earnings: $62.8 million (+9%) Comments: Laboratory Services were $98.9 million in the quarter, up 26%. China-based Lab Services increased 32% to $77.0 million. U.S.-based Lab Services were up 6% to $21.9 million. Manufacturing services were $26.9 million, up 7%....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters